Insights

More Articles Back to Article

China's Sinovac ups output with third production line

China's Sinovac Biotech will produce 2 billion doses of its COVID-19 vaccine with the addition of a third production line that the company said has received approval from China's National Medical Products Administration. Chinese health regulators approved the vaccine for use in February and it has also been approved in 30 other countries. FiercePharma (4/2)

Read full article now.

Articles are only one benefit of being a DIA member. Learn more and join today so you don’t miss another article!